[go: up one dir, main page]

SI2500014T2 - Počasno sproščanje farmacevtskega sestavka narejenega iz mikrodelcev - Google Patents

Počasno sproščanje farmacevtskega sestavka narejenega iz mikrodelcev

Info

Publication number
SI2500014T2
SI2500014T2 SI200832014T SI200832014T SI2500014T2 SI 2500014 T2 SI2500014 T2 SI 2500014T2 SI 200832014 T SI200832014 T SI 200832014T SI 200832014 T SI200832014 T SI 200832014T SI 2500014 T2 SI2500014 T2 SI 2500014T2
Authority
SI
Slovenia
Prior art keywords
microparticles
pharmaceutical composition
slow release
release pharmaceutical
composition made
Prior art date
Application number
SI200832014T
Other languages
English (en)
Other versions
SI2500014T1 (sl
Inventor
Bertrand Ducrey
Patrick Garrouste
Catherine Curdy
Marie-Anne Bardet
Herve Porchet
Eija Lundstrom
Frederic Heimgarten
Original Assignee
Debiopharm International Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40032512&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2500014(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Debiopharm International Sa filed Critical Debiopharm International Sa
Publication of SI2500014T1 publication Critical patent/SI2500014T1/sl
Publication of SI2500014T2 publication Critical patent/SI2500014T2/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200832014T 2007-06-06 2008-06-06 Počasno sproščanje farmacevtskega sestavka narejenega iz mikrodelcev SI2500014T2 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07109767 2007-06-06
IB2007054372 2007-10-27
EP12172232.6A EP2500014B2 (en) 2007-06-06 2008-06-06 Slow release pharmaceutical composition made of microparticles

Publications (2)

Publication Number Publication Date
SI2500014T1 SI2500014T1 (sl) 2019-02-28
SI2500014T2 true SI2500014T2 (sl) 2025-05-30

Family

ID=40032512

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200832014T SI2500014T2 (sl) 2007-06-06 2008-06-06 Počasno sproščanje farmacevtskega sestavka narejenega iz mikrodelcev
SI200831754A SI2164467T1 (sl) 2007-06-06 2008-06-06 Počasno sproščanje farmacevtskega sestavka narejenega iz mikrodelcev

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200831754A SI2164467T1 (sl) 2007-06-06 2008-06-06 Počasno sproščanje farmacevtskega sestavka narejenega iz mikrodelcev

Country Status (32)

Country Link
US (4) US10166181B2 (sl)
EP (3) EP2500014B2 (sl)
JP (1) JP5419169B2 (sl)
KR (1) KR101631475B1 (sl)
CN (1) CN101677959B (sl)
AP (1) AP3000A (sl)
AU (1) AU2008259411B2 (sl)
BR (1) BRPI0812250B8 (sl)
CA (1) CA2688478C (sl)
CO (1) CO6251234A2 (sl)
CY (2) CY1118434T1 (sl)
DK (2) DK2500014T4 (sl)
EA (1) EA019284B1 (sl)
ES (2) ES2611020T3 (sl)
FI (1) FI2500014T4 (sl)
HR (2) HRP20161785T1 (sl)
HU (2) HUE040391T2 (sl)
IL (1) IL202501A (sl)
LT (2) LT2164467T (sl)
MA (1) MA31422B1 (sl)
ME (1) ME00959B (sl)
MX (1) MX2009012856A (sl)
MY (1) MY150450A (sl)
NZ (1) NZ582423A (sl)
PL (2) PL2164467T3 (sl)
PT (2) PT2164467T (sl)
RS (2) RS58248B1 (sl)
SI (2) SI2500014T2 (sl)
TN (1) TN2009000476A1 (sl)
UA (1) UA99830C2 (sl)
WO (1) WO2008149320A2 (sl)
ZA (1) ZA200907940B (sl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20161785T1 (hr) 2007-06-06 2017-03-10 Debiopharm Research & Manufacturing Sa Farmaceutski pripravak sporog oslobađanja pripremljen od mikročestica
PT105270B (pt) 2010-08-26 2012-05-31 Domino Ind Ceramicas S A Camada de sílica com libertação lenta de fragrância, telha cerâmica e respectivo processo de produção
CN105267153B (zh) * 2015-11-27 2018-05-11 上海苏豪逸明制药有限公司 一种曲普瑞林缓释微粒及其制备方法
CN105797134B (zh) * 2016-03-29 2019-06-14 浙江圣兆药物科技股份有限公司 一种难溶亮丙瑞林缓释制剂
US11278629B2 (en) 2016-11-02 2022-03-22 Debiopharm International, S.A. Methods for improving anti-CD37 immunoconjugate therapy
KR102402639B1 (ko) 2017-11-24 2022-05-26 삼성전자주식회사 전자 장치 및 그의 통신 방법
CN111000798B (zh) * 2019-12-26 2021-11-23 四川恒博生物科技有限公司 一种采用原位凝胶技术的犬用非手术去势注射液
IT202000017191A1 (it) 2020-07-15 2022-01-15 Xbrane Biopharma Ab Procedimento senza acqua per preparare una composizione farmaceutica per un rilascio più prolungato e controllato di triptorelina o di un suo sale
TW202504578A (zh) 2023-07-20 2025-02-01 荷蘭商輝凌責任有限公司 緩釋載藥微粒
WO2025099253A1 (en) * 2023-11-08 2025-05-15 Debiopharm International Sa Novel composition
WO2025180339A1 (zh) * 2024-02-29 2025-09-04 珠海市华海康医药科技有限责任公司 一种双羟萘酸盐药物缓释微球及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0190833B1 (en) 1985-02-07 1991-03-27 Takeda Chemical Industries, Ltd. Method for producing microcapsule
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
US5225205A (en) * 1989-07-28 1993-07-06 Debiopharm S.A. Pharmaceutical composition in the form of microparticles
CH679207A5 (sl) * 1989-07-28 1992-01-15 Debiopharm Sa
MY107937A (en) 1990-02-13 1996-06-29 Takeda Chemical Industries Ltd Prolonged release microcapsules.
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
FR2693905B1 (fr) * 1992-07-27 1994-09-02 Rhone Merieux Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
JP3277342B2 (ja) 1992-09-02 2002-04-22 武田薬品工業株式会社 徐放性マイクロカプセルの製造法
JPH09504523A (ja) * 1993-10-22 1997-05-06 ジェネンテク，インコーポレイテッド アジュバントのマイクロカプセル化方法および組成物
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
AR012448A1 (es) * 1997-04-18 2000-10-18 Ipsen Pharma Biotech Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada
JP2001522812A (ja) * 1997-11-07 2001-11-20 カイロン コーポレイション Ｉｇｆ−１持続放出性処方物の作製方法
TW200800298A (en) * 2000-01-27 2008-01-01 Zentaris Ag Compressed microparticles for dry injection
US20040170665A1 (en) * 2000-06-02 2004-09-02 Allergan, Inc. Intravitreal botulinum toxin implant
EP1450766B1 (fr) * 2001-10-10 2015-04-22 Pierre Fabre Medicament Microspheres biodegradables a liberation prolongee et leur procede de preparation
EP1617859A1 (en) * 2003-04-30 2006-01-25 Debiopharm S.A. Methods and compositions using gonadotropin hormone releasing hormone
KR100466637B1 (ko) * 2003-06-26 2005-01-13 주식회사 펩트론 서방성 미립구의 혼합 제형을 연속한 단일 공정으로제조하는 방법
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
PT2359809T (pt) 2005-12-22 2019-11-04 Novartis Ag Formulação de libertação sustentada que compreende octreótido e dois ou mais polímeros poliláctido-co-glicólido
HRP20161785T1 (hr) 2007-06-06 2017-03-10 Debiopharm Research & Manufacturing Sa Farmaceutski pripravak sporog oslobađanja pripremljen od mikročestica

Also Published As

Publication number Publication date
AP2009005088A0 (en) 2009-12-31
EP2500014B2 (en) 2025-02-19
MA31422B1 (fr) 2010-06-01
CY1120891T1 (el) 2019-12-11
PL2500014T3 (pl) 2019-04-30
MX2009012856A (es) 2009-12-15
RS58248B1 (sr) 2019-03-29
AP3000A (en) 2014-10-31
US20190192423A1 (en) 2019-06-27
ZA200907940B (en) 2010-08-25
HUE031550T2 (en) 2017-07-28
AU2008259411A1 (en) 2008-12-11
RS55591B1 (sr) 2017-06-30
PT2164467T (pt) 2017-01-13
LT2164467T (lt) 2017-01-25
BRPI0812250B8 (pt) 2021-05-25
EP2500014A2 (en) 2012-09-19
JP5419169B2 (ja) 2014-02-19
LT2500014T (lt) 2019-01-25
IL202501A0 (en) 2010-06-30
CA2688478A1 (en) 2008-12-11
WO2008149320A3 (en) 2009-02-05
CN101677959A (zh) 2010-03-24
EA200971132A1 (ru) 2010-04-30
IL202501A (en) 2015-11-30
ES2611020T3 (es) 2017-05-04
KR20100023950A (ko) 2010-03-04
KR101631475B1 (ko) 2016-06-20
CA2688478C (en) 2015-10-27
EP2500014A3 (en) 2012-11-07
HUE040391T2 (hu) 2019-03-28
DK2500014T4 (da) 2025-04-14
HRP20161785T1 (hr) 2017-03-10
NZ582423A (en) 2011-10-28
SI2164467T1 (sl) 2017-05-31
PL2164467T3 (pl) 2017-07-31
HRP20181854T1 (hr) 2019-02-08
HK1141737A1 (en) 2010-11-19
US20110052717A1 (en) 2011-03-03
PT2500014T (pt) 2018-11-21
DK2164467T3 (en) 2017-01-30
PL2500014T5 (pl) 2025-05-05
FI2500014T4 (fi) 2025-04-08
US10166181B2 (en) 2019-01-01
AU2008259411B2 (en) 2013-10-17
US20250205148A1 (en) 2025-06-26
ES2694401T5 (es) 2025-05-16
HRP20181854T4 (hr) 2025-05-09
CY1118434T1 (el) 2017-06-28
US20230082575A1 (en) 2023-03-16
EP2164467B1 (en) 2016-12-14
EP2500014B1 (en) 2018-08-08
TN2009000476A1 (en) 2011-03-31
UA99830C2 (uk) 2012-10-10
BRPI0812250A2 (pt) 2014-12-23
CO6251234A2 (es) 2011-02-21
ME00959B (me) 2012-06-20
SI2500014T1 (sl) 2019-02-28
DK2500014T3 (en) 2018-12-03
EP2164467A2 (en) 2010-03-24
MY150450A (en) 2014-01-30
BRPI0812250B1 (pt) 2020-03-03
EP3431077A1 (en) 2019-01-23
ES2694401T3 (es) 2018-12-20
WO2008149320A2 (en) 2008-12-11
EA019284B1 (ru) 2014-02-28
JP2010529106A (ja) 2010-08-26
CN101677959B (zh) 2014-02-26

Similar Documents

Publication Publication Date Title
AP3000A (en) Slow release pharmaceutical composition made of microparticles
PT2345410T (pt) Composição farmacêutica para libertação modificada
EP2308473A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING MICROPARTICLES WITH SURFACE COATING
EP2240173A4 (en) PHARMACEUTICAL COMPOSITION OF DULOXETINE WITH DELAYED RELEASE
PL2251006T3 (pl) Mikrocząstki i ich kompozycje farmaceutyczne
GB2454567B (en) Anti-malarial pharmaceutical composition
IL211886A0 (en) Solid pharmaceutical composition
ZA201100871B (en) Solid pharmaceutical composition
GB0902648D0 (en) Pharmaceutical compounds and compositions
PL2277511T3 (pl) Kompozycje farmaceutyczne lewetiracetamu o przedłużonym uwalnianiu
GB0908317D0 (en) Pharmaceutical compounds and compositions
IL178378A0 (en) Extended release pharmaceutical compositions
GB0903945D0 (en) Pharmaceutical compounds and compositions
GB0919055D0 (en) Pharmaceutical compounds and compositions
GB0902651D0 (en) Pharmaceutical compounds and compositions
GB0908069D0 (en) Pharmaceutical compounds and compositions